Oscar Brück

20PUBLICATIONS
79CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursEpidemiological modellingRegenerative medicine (incl. stem cells)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Feb 16, 2026
Deep cytomorphology identifies erythroid skewing and monocytic morphology to predict TKI sensitivity in CML patients.

Katariina Luukkainen, Mikko Purhonen, Mikael Tatun

|Feb 06, 2026
Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

Theerin Lanamtieng, Anna Mervaala-Muroke, Laura Toivanen

|Nov 10, 2025
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World Data.

Conor J O'Hanlon, Jonas Denck, Elif Ozkirimli

|Sep 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.

Mikko Purhonen, Mikael Tatun, Katariina Luukkainen

|Aug 23, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer.

Brittany L Ford, Emmi Jokinen, Jani Huuhtanen

Pageof 4

Frequent Collaborators

10 joint publications

Satu Mustjoki

4 joint publications

Jani Huuhtanen

3 joint publications

Matti Kankainen

2 joint publications

Naranie Shanmuganathan